The World of Health & Medicine News

WHO validates elimination of trachoma as a public health problem in Libya

WHO validates elimination of trachoma as a public health problem in Libya

The World Health Organization (WHO) today announced that Libya has eliminated trachoma as a public health problem, a landmark victory for public health in WHO’s Eastern Mediterranean Region. This hard-won achievement protects future generations from preventable blindness and provides a powerful reminder that countries can overcome neglected tropical diseases despite persisting challenges.

“This milestone reflects Libya’s determination to safeguard the health of its people and reinforces our conviction that progress against neglected tropical diseases is possible everywhere,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Eliminating trachoma as a public health problem is an inspiring achievement for the Eastern Mediterranean Region and for communities across Libya.”

With this validation, Libya becomes the 28th country worldwide and the 8th in the Eastern Mediterranean Region to eliminate trachoma. The achievement demonstrates how evidence-based programming and coordinated technical support can overcome neglected tropical diseases, even amongst complex humanitarian and migration dynamics.

“Libya joins a growing group of countries from the Eastern Mediterranean Region that have eliminated trachoma,” said Dr Hanan Balkhy, WHO Regional Director for the Eastern Mediterranean. “This result reflects strong regional coordination and Libya’s perseverance during periods of great challenge.”

spot_img

Explore more

spot_img

AstraZeneca’s fixed-duration Calquence combo wins FDA nod as BeOne CLL rivalry...

AstraZeneca's fixed-duration Calquence combo wins FDA nod as BeOne CLL rivalry heats up AstraZeneca has secured a key regulatory win in its effort to reclaim the lead...

US FDA approves Vanda’s antipsychotic pill

US FDA approves Vanda's antipsychotic pill The U.S. Food and Drug Administration has approved Vanda Pharmaceuticals' drug for the treatment of two serious mental health...

The 7 Common Causes Behind Tinnitus Ringing Ears

The 7 Common Causes Behind Tinnitus Ringing Ears Tinnitus affects nearly 50 million Americans, yet many people don't fully understand what causes it or how...

10 Health Benefits of Eating Dates

10 Health Benefits of Eating Dates There are many benefits to eating dates, including providing many nutrients and antioxidants, having anti-inflammatory and anti-tumor properties, promoting...

Combining GLP-1 drugs with hormones may lower uterine cancer risk

Combining GLP-1 drugs with hormones may lower uterine cancer risk Adding GLP-1 medications like Ozempic to progestin therapy could cut the risk of developing endometrial...

The 10 Best High-Fiber Foods to Eat for Breakfast, According to...

The 10 Best High-Fiber Foods to Eat for Breakfast, According to a Dietitian No matter what time your day starts, the first meal sets the...

AstraZeneca reveals oral GLP-1 scored phase 2 wins but holds back...

AstraZeneca reveals oral GLP-1 scored phase 2 wins but holds back weight loss data AstraZeneca is taking its oral GLP-1 drug into phase 3 on...

EMA recommends withdrawal of marketing authorisations for levamisole medicines

EMA recommends withdrawal of marketing authorisations for levamisole medicines EMA’s safety committee (PRAC) recommended that medicines containing levamisole be withdrawn from the EU market. This...